Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Mackness

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Current Opinion in Lipidology|July 10, 2004
Paraoxonase 1 activity, concentration and genotype in cardiovascular diseaseMike Mackness, Paul Durrington, Bharti Mackness
Free Radical Biology & Medicine|July 1, 2008
Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stressYifen Liu, Bharti Mackness, Mike Mackness
Diabetes|October 27, 2006
Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetesMaria Mastorikou, Mike Mackness, Bharti Mackness
IUBMB Life|December 21, 2011
Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidationDavid Hine, Bharti Mackness, Mike Mackness
Archives of Medical Science : AMS|March 22, 2013
Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart diseaseBharti Mackness, Wajdi Turkie, Mike Mackness
Biochemical and Biophysical Research Communications|May 18, 2004
Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cellsBharti Mackness, David Hine, Yifen Liu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2006
Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndromeBharti Mackness, Rozenn Quarck, Wim Verreth, et al.
Clinical Biochemistry|July 29, 2019
The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulationAbdolkarim Mahrooz, Mike Mackness, Abouzar Bagheri, et al.
Atherosclerosis|April 7, 2007
Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levelsWimon Phuntuwate, Chuthamanee Suthisisang, Banhan Koanantakul, et al.
IUBMB Life|May 27, 2010
Human tissue distribution of paraoxonases 1 and 2 mRNABharti Mackness, Raul Beltran-Debon, Gerard Aragones, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Current Opinion in Lipidology|July 10, 2004
Paraoxonase 1 activity, concentration and genotype in cardiovascular diseaseMike Mackness, Paul Durrington, Bharti Mackness
Free Radical Biology & Medicine|July 1, 2008
Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stressYifen Liu, Bharti Mackness, Mike Mackness
Diabetes|October 27, 2006
Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetesMaria Mastorikou, Mike Mackness, Bharti Mackness
IUBMB Life|December 21, 2011
Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidationDavid Hine, Bharti Mackness, Mike Mackness
Archives of Medical Science : AMS|March 22, 2013
Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart diseaseBharti Mackness, Wajdi Turkie, Mike Mackness
Biochemical and Biophysical Research Communications|May 18, 2004
Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cellsBharti Mackness, David Hine, Yifen Liu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2006
Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndromeBharti Mackness, Rozenn Quarck, Wim Verreth, et al.
Clinical Biochemistry|July 29, 2019
The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulationAbdolkarim Mahrooz, Mike Mackness, Abouzar Bagheri, et al.
Atherosclerosis|April 7, 2007
Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levelsWimon Phuntuwate, Chuthamanee Suthisisang, Banhan Koanantakul, et al.
IUBMB Life|May 27, 2010
Human tissue distribution of paraoxonases 1 and 2 mRNABharti Mackness, Raul Beltran-Debon, Gerard Aragones, et al.
Pageof 4